JournalClubNew.pptVIP

  1. 1、本文档共26页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
JournalClubNew

Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced HeadNeck Cancer Background Local recurrences and distant metastases are frequent after surgery of stage III or IV HN squamous-cell carcinoma Particularly with inadequate resection margins, extranodal spread, or multiple involved lymph nodes. Background For locally advanced tumors, surgery is usually followed by adjuvant radiotherapy Combined therapy is a promising approach Objective Whether the addition of cisplatin to high-dose radiotherapy after radical surgery increases PFS in patients at high risk for recurrent cancer. Overall survival, relapse, and acute and late adverse effects. Eligibility Age from 18 to 70 Performance status of 0,1,2 WBC4000 /ml, PLT100,000 /ml HGB110g/ml Cr120 μmol /L ALT,AST80U/L STB34.2 μmol /L CB13.6 μmol /L Eligibility Untreated after operation Histologically: squamous-cell Ca From the oral cavity, oropharynx, hypopharynx,or larynx T3,T4,any N(except for T3N0 of the larynx);N2,N3 any T;and M0 Negative resection margins Method Method 4 to 6 MV-X; Isocentric techniques CTV DT 54 Gy/ 27f/ 5.5 W Regions that were at high risk for malignant dissemination or that had inadequate resection margins received a 12-Gy boost (total, 66 Gy/33f/ 6.5 W) Method Cisplatin 100 mg/m2 on D1, D22, and D43 of the course of radiotherapy Prophylactic hydration and antiemetic agents. Method Follow-up evaluation items: Tumor response Adverse effects Weight Performance status Results Characteristics of Tumors Results Characteristics of Tumors Results Characteristics of Tumors Results Follow-up Times (Month) Results Progress-free Survival Results Progress-free Survival Results Overall Survival Results Overall Survival Results Severe acute adverse effects(%) Results Only severe chemotherapy-related adverse effect(%) Results Late Adverse Effects of Grade 3 or Higher Results Late Adverse Effects of Grade 3 or Higher Results Other Secondary e

文档评论(0)

panguoxiang + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档